234 related articles for article (PubMed ID: 16820420)
1. A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer's disease.
Tárraga L; Boada M; Modinos G; Espinosa A; Diego S; Morera A; Guitart M; Balcells J; López OL; Becker JT
J Neurol Neurosurg Psychiatry; 2006 Oct; 77(10):1116-21. PubMed ID: 16820420
[TBL] [Abstract][Full Text] [Related]
2. Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.
Ibarria M; Alegret M; Valero S; Morera A; Guitart M; Cañabate P; Moreno M; Lara S; Diego S; Hernández J; Tantinyá N; Vera M; Hernández I; Becker JT; Ruíz A; Boada M; Tárraga L
J Alzheimers Dis; 2016; 50(2):559-66. PubMed ID: 26757182
[TBL] [Abstract][Full Text] [Related]
3. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
Wattmo C; Wallin ÅK
Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660
[TBL] [Abstract][Full Text] [Related]
4. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
De Jesus Moreno Moreno M
Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119
[TBL] [Abstract][Full Text] [Related]
5. Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study.
Sjögren MJ; Hellström PT; Jonsson MA; Runnerstam M; Silander HC; Ben-Menachem E
J Clin Psychiatry; 2002 Nov; 63(11):972-80. PubMed ID: 12444809
[TBL] [Abstract][Full Text] [Related]
6. Repetitive transcranial magnetic stimulation (rTMS) combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: clinical experience.
Rabey JM; Dobronevsky E
J Neural Transm (Vienna); 2016 Dec; 123(12):1449-1455. PubMed ID: 27631152
[TBL] [Abstract][Full Text] [Related]
7. ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.
Gault LM; Lenz RA; Ritchie CW; Meier A; Othman AA; Tang Q; Berry S; Pritchett Y; Robieson WZ
Alzheimers Res Ther; 2016 Oct; 8(1):44. PubMed ID: 27756421
[TBL] [Abstract][Full Text] [Related]
8. The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group.
Raskind MA; Cyrus PA; Ruzicka BB; Gulanski BI
J Clin Psychiatry; 1999 May; 60(5):318-25. PubMed ID: 10362441
[TBL] [Abstract][Full Text] [Related]
9. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.
Riepe MW; Adler G; Ibach B; Weinkauf B; Tracik F; Gunay I
Dement Geriatr Cogn Disord; 2007; 23(5):301-6. PubMed ID: 17356273
[TBL] [Abstract][Full Text] [Related]
10. Effects of AZD3480 on cognition in patients with mild-to-moderate Alzheimer's disease: a phase IIb dose-finding study.
Frölich L; Ashwood T; Nilsson J; Eckerwall G;
J Alzheimers Dis; 2011; 24(2):363-74. PubMed ID: 21258153
[TBL] [Abstract][Full Text] [Related]
11. Donepezil for dementia due to Alzheimer's disease.
Birks JS; Harvey RJ
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001190. PubMed ID: 29923184
[TBL] [Abstract][Full Text] [Related]
12. Effects of a multidisciplinary cognitive rehabilitation program for patients with mild Alzheimer's disease.
Viola LF; Nunes PV; Yassuda MS; Aprahamian I; Santos FS; Santos GD; Brum PS; Borges SM; Oliveira AM; Chaves GF; Ciasca EC; Ferreira RC; Paula VJ; Takeda OH; Mirandez RM; Watari R; Falcao DV; Cachioni M; Forlenza OV
Clinics (Sao Paulo); 2011; 66(8):1395-400. PubMed ID: 21915490
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine does not enhance cognition in non-agitated and non-psychotic patients with mild to moderate Alzheimer's dementia.
Kennedy J; Deberdt W; Siegal A; Micca J; Degenhardt E; Ahl J; Meyers A; Kaiser C; Baker RW
Int J Geriatr Psychiatry; 2005 Nov; 20(11):1020-7. PubMed ID: 16250069
[TBL] [Abstract][Full Text] [Related]
14. Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24-week, Randomized, Double-Blind Parallel-Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily).
Zhang ZX; Hong Z; Wang YP; He L; Wang N; Zhao ZX; Zhao G; Shang L; Weisskopf M; Callegari F; Strohmaier C
CNS Neurosci Ther; 2016 Jun; 22(6):488-96. PubMed ID: 27012596
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D
Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693
[TBL] [Abstract][Full Text] [Related]
16. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.
Morris JC; Cyrus PA; Orazem J; Mas J; Bieber F; Ruzicka BB; Gulanski B
Neurology; 1998 May; 50(5):1222-30. PubMed ID: 9595967
[TBL] [Abstract][Full Text] [Related]
17. Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study.
Canevelli M; Adali N; Kelaiditi E; Cantet C; Ousset PJ; Cesari M;
Phytomedicine; 2014 May; 21(6):888-92. PubMed ID: 24548724
[TBL] [Abstract][Full Text] [Related]
18. An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data.
Ben Jemaa S; Attia Romdhane N; Bahri-Mrabet A; Jendli A; Le Gall D; Bellaj T
J Alzheimers Dis; 2017; 60(1):11-21. PubMed ID: 28505978
[TBL] [Abstract][Full Text] [Related]
19. The Alzheimer's Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials.
Doraiswamy PM; Bieber F; Kaiser L; Krishnan KR; Reuning-Scherer J; Gulanski B
Neurology; 1997 Jun; 48(6):1511-7. PubMed ID: 9191757
[TBL] [Abstract][Full Text] [Related]
20. Cognitive rehabilitation combined with drug treatment in Alzheimer's disease patients: a pilot study.
Bottino CM; Carvalho IA; Alvarez AM; Avila R; Zukauskas PR; Bustamante SE; Andrade FC; Hototian SR; Saffi F; Câmargo CH
Clin Rehabil; 2005 Dec; 19(8):861-9. PubMed ID: 16323385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
